Therapeutic Class Antidiabetic / Anti-obesity Agent Action Class Incretin Mimetic Chemical Class Dual GIP and GLP-1 Receptor Agonist Habit Forming No Checkout Editorial Policy Tirzepatide 2.5mg 2,821.9 MRP 3,281.3 Tirzepatide 5mg 3,527.3 MRP 4,101.6 Tirzepatide 5mg 14,109.4 MRP 16,406.3 Tirzepatide 2.5mg 11,287.5 MRP 13,125 Tirzepatide 7.5mg 17,737.5 MRP 20,625 Tirzepatide 15mg 22,171.9 MRP 25,781.3 Tirzepatide 12.5mg 22,171.9 MRP 25,781.3 Tirzepatide 10mg 17,737.5 MRP 20,625 Tirzepatide 2.5mg 13,125 11,287.5 MRP 13,125 Tirzepatide 5mg 16,406.3 14,109.4 MRP 16,406.3 Tirzepatide 12.5mg 25,781.3 22,171.9 MRP 25,781.3 Tirzepatide 7.5mg 20,625 17,737.5 MRP 20,625 Tirzepatide 10mg 20,625 17,737.5 MRP 20,625 Tirzepatide 15mg 25,781.3 22,171.9 MRP 25,781.3 Tirzepatide 12.5mg 25,781 22,171.9 MRP 25,781.3 Tirzepatide 2.5mg 13,125 11,287.5 MRP 13,125 Tirzepatide 5mg 16,406.3 14,109.4 MRP 16,406.3 Tirzepatide 7.5mg 20,625 17,737.5 MRP 20,625
It is approved for adults and children aged 12 and older with obesity or overweight with weight-related health problems
Insulin syringes, for the small volumes
In vitro studies have quantified this bioavailability
